What is Revelation Biosciences, Inc. Common Stock's Market Cap?

Revelation Biosciences, Inc. Common Stock's Market Cap is $4.0M, based on as-reported figures from SEC (XBRL) filings.

What is Revelation Biosciences, Inc. Common Stock's Enterprise Value?

Revelation Biosciences, Inc. Common Stock's Enterprise Value is -$7.5M, based on as-reported figures from SEC (XBRL) filings.

What is Revelation Biosciences, Inc. Common Stock's EV / EBITDA?

Revelation Biosciences, Inc. Common Stock's EV / EBITDA is 0.7×, based on as-reported figures from SEC (XBRL) filings.

What is Revelation Biosciences, Inc. Common Stock's Net Income (TTM)?

Revelation Biosciences, Inc. Common Stock's Net Income (TTM) is -$10.8M, based on as-reported figures from SEC (XBRL) filings.

What is Revelation Biosciences, Inc. Common Stock's EBITDA?

Revelation Biosciences, Inc. Common Stock's EBITDA is -$11.2M, based on as-reported figures from SEC (XBRL) filings.

What is Revelation Biosciences, Inc. Common Stock's Diluted EPS (TTM)?

Revelation Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -2.70, based on as-reported figures from SEC (XBRL) filings.

What is Revelation Biosciences, Inc. Common Stock's Net Debt?

Revelation Biosciences, Inc. Common Stock's Net Debt is -$11.5M, based on as-reported figures from SEC (XBRL) filings.

Revelation Biosciences, Inc. Common Stock (REVB) Financial Statements

Revelation Biosciences, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00WH4GC08

XNAS · usd

1.01▲ 0.00 (0.00%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.01

Day's Range1.00 – 1.04

52-Week Range0.47 – 2.90

Volume16.0K

Avg Volume34.2K

Share Statistics

Shares Outstanding

Employees9

ExchangeXNAS

Listed2022-01-11

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Revelation Biosciences, Inc. Common Stock (REVB)

What is Revelation Biosciences, Inc. Common Stock's Market Cap?: Revelation Biosciences, Inc. Common Stock's Market Cap is $4.0M, based on as-reported figures from SEC (XBRL) filings.
What is Revelation Biosciences, Inc. Common Stock's Enterprise Value?: Revelation Biosciences, Inc. Common Stock's Enterprise Value is -$7.5M, based on as-reported figures from SEC (XBRL) filings.
What is Revelation Biosciences, Inc. Common Stock's EV / EBITDA?: Revelation Biosciences, Inc. Common Stock's EV / EBITDA is 0.7×, based on as-reported figures from SEC (XBRL) filings.
What is Revelation Biosciences, Inc. Common Stock's Net Income (TTM)?: Revelation Biosciences, Inc. Common Stock's Net Income (TTM) is -$10.8M, based on as-reported figures from SEC (XBRL) filings.
What is Revelation Biosciences, Inc. Common Stock's EBITDA?: Revelation Biosciences, Inc. Common Stock's EBITDA is -$11.2M, based on as-reported figures from SEC (XBRL) filings.
What is Revelation Biosciences, Inc. Common Stock's Diluted EPS (TTM)?: Revelation Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -2.70, based on as-reported figures from SEC (XBRL) filings.
What is Revelation Biosciences, Inc. Common Stock's Net Debt?: Revelation Biosciences, Inc. Common Stock's Net Debt is -$11.5M, based on as-reported figures from SEC (XBRL) filings.